Acrixolimab

Modify Date: 2024-04-12 07:57:17

Use of Acrixolimab

Acrixolimab a humanized IgG4-κ antibody, targeting to PD-1[1][2].

Name	Acrixolimab

Description	Acrixolimab a humanized IgG4-κ antibody, targeting to PD-1[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Immunology/Inflammation >> PD-1/PD-L1
References	[1]. Kiratikanon S, et al. Acrixolimab-Induced Radiation Recall Dermatitis with Distinct Features Resembling Erythema Multiforme[J]. Thai Journal of Dermatology, 2023, 39(2): 35-38. [2]. Acrixolimab. IMGT/mAb-DB.

Description

Acrixolimab a humanized IgG4-κ antibody, targeting to PD-1[1][2].

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> Immunology/Inflammation >> PD-1/PD-L1

References

No Any Chemical & Physical Properties